Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1

OBJECTIVES 1) To evaluate the outcome of patients with peripartum cardiomyopathy (PPC) on current treatment for heart failure, 2) to assess the: circulating plasma levels of cytokines and Fas receptors and 3) to identify predictors of prognosis. BACKGROUND Previous studies in patients with PPC were done when angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic blocking agents were not routinely used in heart failure. Inflammatory cytokines play an important role in the pathogenesis and progression of heart failure of other etiologies. However,:there is a paucity of data regarding cytokine expression in patients with PPC. Plasma:concentrations of Fas receptors tan apoptosis-signalling receptor) have not been reported-in this population. METHODS We followed prospectively 29 consecutive black women with PPC. All patients were treated with diuretics, digoxin, enalapril and carvedilol. Echocardiograms were performed at baseline and after six months of treatment. Cytokine and soluble Fas/APO-1 plasma levels were measured at baseline. RESULTS Tumor necrosis factor-alpha, interleukin-6 and Fas/APO-1 levels were significantly elevated in the study patients compared with 20 healthy volunteers. Eight patients died. sFas/APO-1 levels were significantly higher in patients who died compared with survivors (8.98 +/- 4.5 vs. 5.33 +/- 3 U/ml, respectively, p = 0.02). Ar:six;months, ejection fraction improved from 26.7 +/- 10 to 42.7 +/- 16%, p = 0.00003, with-an increment of more than 10 U in 10 patients (28.1 +/- 4 to 51.9 +/- 8%, p = 0.000008). CONCLUSIONS Cytokine and sFas levels are elevated id patients with PPC. Despite treatment with ACE inhibitors and beta-blockers, mortality :remains high. However, in 34% of the patients, left ventricular function almost completely normalized. (C) 2000 by the American College of Cardiology.